Discovery of α2-plasmin inhibitor and its congenital deficiency

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 4, 2005, Pages 623-631

  Aoki, N ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; ALPHA 2 GLOBULIN; ALPHA 2 MACROGLOBULIN; AMINOCAPROIC ACID; APROTININ; PLASMIN; PLASMIN INHIBITOR; TRANEXAMIC ACID; ANTIPLASMIN;

BLEEDING; BLOOD CLOTTING FACTOR 13 DEFICIENCY; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG PURIFICATION; DRUG RESEARCH; FIBRINOLYSIS; HEMOPHILIA; HEMOSTASIS; HUMAN; IMMUNOELECTROPHORESIS; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; ADOLESCENT; ARTICLE; BIOLOGICAL MODEL; CHEMISTRY; FEMALE; HEMATOLOGY; HISTORY; JAPAN; MALE; NOMENCLATURE; PEDIGREE; PHYSIOLOGY; TIME; UNITED STATES;

ADOLESCENT; ANTIPLASMIN; FEMALE; HEMATOLOGY; HISTORY, 20TH CENTURY; HUMANS; JAPAN; MALE; MODELS, BIOLOGICAL; PEDIGREE; TERMINOLOGY; TIME FACTORS; UNITED STATES;

EID: 23044485066     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.01055.x     Document Type: Review

References (47)

1. 2- plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. J Biol Chem 1976; 251: 5956-65.
2. Collen D. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. Eur J Biochem 1976; 69: 209-16.
3. Müllertz S, Clemmensen I. The primary inhibitor of plasmin in human plasma. Biochem J 1976; 159: 545-53.
4. Norman PS, Hill BM. Studies of plasmin system. III. Physical properties of two plasmin inhibitors. J Exp Med 1958; 108: 639-49.
5. 2- macroglobulin. Clin Chim Acta 1967; 16: 328-30.
6. Rimon A, Shamash Y, Shapiro B. The plasmin inhibition of human plasma. J Biol Chem 1966; 241: 5102-7.
7. von Kaulla KN, Ens G. On struture-related properties of synthetic organic clot-dissolving (thrombolytic) compounds. Biochem Pharmacol 1967; 16: 1023-34.
8. Aoki N, von Kaulla KN. Inactivation of human serum plasminogen antiactivator by synthetic fibrinolysis inducers. Thromb Diath Haemorrh 1969; 22: 251-62.
9. Aoki N, von Kaulla KN. Human serum plasminogen antiactivator: its distinction from antiplasmin. Am J Physiol 1971; 220: 1137-45.
10. Aoki N, von Kaulla KN. The extraction of vascular plasminogen activator from human cadavers and a description of some of its properties. Am J Clin Pathol 1971; 55: 171-9.
11. 1C-Globulin and synthetic fibrinolytic agents. Proc Soc Exp Biol Med 1969; 130: 101-6.
12. 1-antitrypsin. Proc Soc Exp Biol Med 1974; 146: 567-70.
13. Hedner U. Studies on an inhibitor of plasminogen activation in human serum. Thromb Diath Haemorrh 1973; 30: 414-24.
14. 2- macroglobulin. Thromb Haemost 1978; 39: 22-31.
15. 2-plasmin inhibitor in fibrinolytic states. J Clin Invest 1977; 60: 361-9.
16. Müllertz S. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin. Biochem J 1974; 143: 273-83.
17. 1-antitrypsin. Thromb Res 1975; 7: 245-9.
18. Hedner U, Gallimore M. Two human immunochemically distinct low molecular fibrinolytic inhibitors. Thromb Haemost 1977; 38: 145 (Abstract).
19. Wiman B, Collen D. Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasma. Eur J Biochem 1977; 78: 19-26.
20. 2-plasmin inhibitor. J Biochem 1977; 82: 969-72.
21. 2-plasmin inhibitor. Proc Natl Acad Sci USA 1979; 76: 2013-7.
22. 2-plasmin inhibitor. Thromb Res 1977; 10: 851-6.
23. 2-plasmin inhibitor on adsorption of plasminogen to fibrin. Thromb Res 1980; 19: 149-55.
24. 2-plasmin inhibitor in inhibition of plasminogen binding to fibrin. Thromb Res 1984; 33: 401-7.
25. 2-plasmin inhibitor to fibrin. Thromb Res 1979; 16: 279-82.
26. 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest 1980; 65: 290-7.
27. 2- plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. J Clin Invest 1982; 69: 536-42.
28. 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor. J Biol Chem 1982; 257: 14767-72.
29. 2-plasmin inhibitor. J Biol Chem 1986; 261: 15591-5.
30. Blombäck M, Abildgaard U, van den Besselaar AMHP, Clementson KJ, Dahlbäck B, Exner T, Francis CW, Gaffney P, Gralnick H, Hoyer LW, Johnson GJ, Kasper C, Lane D, Lijnen HR, Lusher JM, Mannucci PM, Poller SI, Rapaport SI, Saito H, Stocker K, Thomas D, Barrowcliffe TW, Hemker C, Thorsen S, Aronson D, Mann KG, Meyer D, Roberts HR, Dybkaer R, Jogensen K, Olesen H. Nomenclature of quantities and units in thrombosis and haemostasis (recommendation 1993). Thromb Haemost 1994; 71: 375-94.
31. Yoshinaga H, Hirosawa S, Chung DH, Miyasaka N, Aoki N, Favier R. A novel point mutation of the splicing donor site in the intron 2 of the plasmin inhibitor gene. Thromb Haemost 2000; 84: 307-11.
32. Yoshinaga H, Nakahara M, Koyama T, Shibamiya A, Nakazawa F, Miles LA, Hirosawa S, Aoki N. A single thymine nucleotide deletion responsible for congenital deficiency of plasmin inhibitor. Thromb Haemost 2002; 88: 144-8.
33. Jansen JWCM, Haverkate F, Koopman J, Nieuwenhuis HK, Kluft C, Boschman ThAc. Influence of factor XIIIa activity on human whole blood clot lysis in vitro. Thromb Haemost 1987; 57: 171-5.
34. 2-plasmin inhibitor associated with severe hemorrhagic tendency. J Clin Invest 1979; 63: 877-84.
35. 2-plasmin inhibitor. Blood 1980; 55: 483-8.
36. 2- plasmin inhibitor in a patient with its congenital deficiency. Thromb Res 1981; 22: 281-6.
37. Collen D, Wiman B. Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma. Blood 1979; 53: 313-24.
38. 2-plasmin inhibitor deficiency. Blood 1983; 62: 1118-22.
39. 2-plasmin inhibitor deficient plasma. Role of fibrin. Thromb Res 1986; 41: 847-54.
40. Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 1982; 257: 2912-9.
41. Aoki N, Harpel PC. Inhibitors of the fibrinolytic system. Semin Thromb Hemost 1984; 10: 24-41.
42. Robbie LA, Bennet B, Keyt BA, Booth NA. Effective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha2-antiplasmin. Br J Haematol 2000; 111: 517-23.
43. 2-plasmin inhibitor deduced from that of cDNA. J Biochem 1986; 100: 1399-402.
44. 2-plasmin inhibitor gene. Proc Natl Acad Sci USA 1988; 85: 6836-40.
45. 2PI- Okinawa). Deletion of Glu137 by a trinucleotide deletion blocks intracellular transport. J Biol Chem 1989; 264: 18213-9.
46. Miura O, Sugahara Y, Aoki N. Intracellular transport-deficient mutants causing hereditary deficiencies of factors involved in coagulation and fibrinolysis. Thromb Haemost 1993; 69: 296-7.
47. 2-plasmin inhibitor. Blood 1990; 75: 1092-6.